InMode Ltd (INMD) Stock Analysis

InMode Ltd (INMD) is a publicly traded company in the HEALTHCARE sector. It trades at $13.50, carries a market capitalization of $826.39M, a price-to-earnings ratio of 10.07. This page summarizes the public market data, fundamentals, and frequently asked questions for INMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $13.50
• Market Cap: $826.39M
• P/E Ratio: 10.07
• EPS: $1.35
• 52-Week High: $16.74
• 52-Week Low: $12.72

Market Sentiment

InMode Ltd currently has a Bullish sentiment score of 0.42.

About InMode Ltd

InMode Ltd. (INMD) is a pioneering company in minimally invasive aesthetic medicine, recognized for its advanced medical devices that utilize proprietary radiofrequency-assisted technologies. Based in Yokneam, Israel, the company has built a robust portfolio that includes innovative solutions for body contouring, skin rejuvenation, and surgical procedures, all designed to enhance patient safety and treatment outcomes. As demand for non-invasive aesthetic treatments continues to surge globally...

GNG Research Analysis

GNG Research scores InMode Ltd (INMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INMD.

Frequently Asked Questions

Does INMD pay dividends?

InMode Ltd (INMD) does not currently pay a regular dividend.

What is INMD's P/E ratio?

InMode Ltd has a price-to-earnings (P/E) ratio of 10.07.

What is INMD's market cap?

InMode Ltd (INMD) has a market capitalization of $826.39M with a current stock price of $13.50.